|
You are here: Home: BCU 5|2004: Editor's office
EDITOR
Neil Love, MD
ASSOCIATE EDITORS
Michelle Paley, MD
Richard Kaderman, PhD
WRITERS
Lilliam Sklaver Poltorack,
PharmD
Sally Bogert, RNC, WHCNP
Douglas Paley
Margaret Peng
Nelson Vega
CME DIRECTOR
Michelle Paley, MD
ART DIRECTOR
Albert Rosado
SENIOR DESIGNER
Tamara Dabney
PRODUCTION ARTIST
Ben Belin
PRODUCTION EDITOR
Aura Herrmann
ASSOCIATE PRODUCTION
EDITOR
Alexis Oneca
|
COPY EDITORS
Sandy Allen
Pat Morrissey/Havlin
AUDIO PRODUCTION
Frank Cesarano
TECHNICAL SERVICES
Arly Ledezma
WEB DESIGN
John Ribeiro
PRODUCTION COORDINATOR
Cheryl Dominguez
EDITORIAL ASSISTANTS
Vanessa Dominguez
Patricia McWhorter
Arai Peñate
Raquel Segura
Tere Sosa
Arlene Thorstensen
Melissa Vives |
CONTACT INFORMATION:
Neil Love, MD
Director, Physician and Community Education
RESEARCH TO PRACTICE
One Biscayne Tower
2 South Biscayne Boulevard, Suite 3600
Miami, FL 33131
Fax: (305) 377-9998
Email: nlove@researchtopractice.net |
© Research To Practice, 2004. All rights reserved.
This program was supported by education grants from AstraZeneca Pharmaceuticals, LP; Genentech, Inc.; Roche Laboratories, Inc. and Amgen, Inc.
The audio tapes, compact discs, Internet content and accompanying printed material are protected by copyright. No part of this program may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording or utilizing any information storage and retrieval system, without written permission from the copyright owner.
The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantor.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management.
Any procedures, medications or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information and comparison with recommendations of other authorities.
|
|
